Aclaris Therapeutics Inc (ACRS) recent activity suggests a positive outlook with the last week’s performance of -6.78%
On Tuesday, Aclaris Therapeutics Inc (NASDAQ: ACRS) was -2.65% drop from the session before settling in for the closing price of $1.13. A 52-week range